Van Looveren RX, radiologie BV
0735.850.611 · rovalta.com · 23/09/2026
Van Looveren RX, radiologie BV
Overview
What does Van Looveren RX, radiologie BV do?
Van Looveren RX, radiologie BV is a Private limited company incorporated in 2019. Its registered office is in Schilde.
2970 Schilde · FlandreSee on map
Trend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Gross margin | 832,5 k € | -0.1% | 833,1 k € | +5.7% | 788,4 k € | +11.5% | 707,1 k € | +19.0% | 594,3 k € | +227% | 181,5 k € |
| EBITDA | 832 k € | -0.0% | 832 k € | +5.7% | 787,2 k € | +11.5% | 706,2 k € | +19.0% | 593,6 k € | +228% | 180,8 k € |
| Operating result | 807,3 k € | -0.8% | 814,2 k € | +5.6% | 771,2 k € | +11.7% | 690,8 k € | +19.5% | 578,1 k € | +227% | 177 k € |
| Net result | 605 k € | -1.8% | 616,1 k € | +5.4% | 584,5 k € | +12.8% | 518,3 k € | +19.6% | 433,6 k € | +224% | 133,7 k € |
| Balance sheet | |||||||||||
| Equity | 100 € | -100.0% | 616,2 k € | +5.4% | 584,6 k € | +12.7% | 518,5 k € | -42.4% | 899,5 k € | +572% | 133,8 k € |
| Total assets | 610,9 k € | -8.3% | 665,9 k € | -19.5% | 826,9 k € | +16.5% | 710 k € | -32.4% | 1,1 M € | +261% | 290,9 k € |
| Cash | 8,7 k € | -89.2% | 80,6 k € | -73.4% | 303,2 k € | +49.0% | 203,6 k € | -64.8% | 579 k € | +3118% | 18 k € |
| Debts | 610,2 k € | +1144% | 49,1 k € | -79.7% | 241,8 k € | +26.6% | 191 k € | +29.4% | 147,5 k € | -6.1% | 157,1 k € |
| Other | |||||||||||
| Workforce | 0,0 ETP | 0,0 ETP | 0,0 ETP | – | – | – | |||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/04/2026 | 29/04/2025 | 26/04/2024 | 28/06/2023 | 25/08/2022 | 29/07/2021 |
| General meeting | 24/04/2026 | 25/04/2025 | 26/04/2024 | 15/06/2023 | 29/04/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
7 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 24/04/2026 | 28/04/2026 | Dutch | |
| Abridged model | 31/12/2024 | 25/04/2025 | 29/04/2025 | Dutch | |
| Abridged model | 31/12/2023 | 26/04/2024 | 26/04/2024 | Dutch | |
| Micro model | 31/12/2022 | 15/06/2023 | 28/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 29/04/2022 | 25/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 30/06/2021 | 29/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 24/04/2020 | 15/05/2020 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025605 k €↓
- 2024Annual accounts 2024616,1 k €↑
- 2023Annual accounts 2023584,5 k €↑
- 2022Annual accounts 2022518,3 k €↑
- 2021Annual accounts 2021433,6 k €↑
- 2019Annual accounts 2019133,7 k €
- 08/10/2019IncorporationPrivate limited company